S. Suresh

Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models

J. Melo, T. Holyoake, M. Aujay, 2014, Oncogenesis.

Inhibition of nucleo-cytoplasmic shuttling through XPO1/CRM1: a unique therapeutic approach for treatment of haematological and solid malignancies

T. Ganesan, M. Garg, Ram Shankar, 2017 .

The combination of RAD 001 and NVP-BKM 120 synergistically inhibits the growth of lung cancer in vitro and in vivo

Ramalingam, F. Khuri, T. Owonikoko, 2012 .

Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

T. Ganesan, E. Baloglu, J. Said, 2017, Scientific Reports.